-
-
-
-
-
Good news: More women are choosing long-acting reversible contraceptives (LARC methods) such as the intrauterine device (IUD) and the contraceptive implant.
-
The Centers for Disease Control and Prevention (CDC) has issued new interim guidance for use of pre-exposure prophylaxis (PrEP) for in heterosexual men and women at high risk for HIV.
-
Findings from a just-published study of young women ages 13-16 in Cincinnati are the first to document herd protection after introduction of the human papillomavirus (HPV) vaccine.
-
The North American Menopause Society, the American Society for Reproductive Medicine, and The Endocrine Society have issued a joint statement concluding that hormone therapy (HT) is still an acceptable treatment for menopausal symptoms.
-
Two sister studies have been launched in Africa to evaluate the ability of a new monthly vaginal ring containing the antiretroviral drug dapivirine to safely prevent new HIV infections in women.
-
Update your practice: The Centers for Disease Control and Prevention (CDC) no longer recommends the oral antibiotic cefixime as a first-line treatment option for gonorrhea due to possible drug resistance.
